Growth Hormone Use in Cystic Fibrosis - a Multicenter Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00005112 |
Recruitment Status :
Completed
First Posted : April 17, 2000
Last Update Posted : June 24, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cystic Fibrosis | Drug: Human recombinant growth hormone | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Primary Purpose: | Treatment |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 5 Years to 12 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- CF patients ages 5-12 who are less than the 25th percentile for age and sex normal values for height and/or weight

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005112
United States, Texas | |
University of Texas Medical School | |
Houston, Texas, United States, 77030 | |
United States, Utah | |
University of Utah, Dept of Pediatric Endocrinology | |
Salt Lake City, Utah, United States, 84132 |
Principal Investigator: | Dana Hardin, M.D. |
ClinicalTrials.gov Identifier: | NCT00005112 |
Obsolete Identifiers: | NCT00000109 |
Other Study ID Numbers: |
NCRR-M01RR02558-0111 M01RR002558 ( U.S. NIH Grant/Contract ) |
First Posted: | April 17, 2000 Key Record Dates |
Last Update Posted: | June 24, 2005 |
Last Verified: | December 2003 |
Cystic Fibrosis Fibrosis Pathologic Processes Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs |